QR Kodea

Stability and Formulation of Erlotinib in Skin Creams

Recent studies have highlighted the benefit of repurposing oral erlotinib (ERL) treatment in some rare skin diseases such as Olmsted syndrome. The use of a topical ERL skin treatment instead of the currently available ERL tablets may be appealing to treat skin disorders while reducing adverse system...

Deskribapen osoa

Gorde:
Egile Nagusiak: David Nguyen, Philippe-Henri Secrétan, Camille Cotteret, Emmanuelle Jacques-Gustave, Céline Greco, Christine Bodemer, Joel Schlatter, Salvatore Cisternino
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2022-02-01
Saila:Molecules
Gaiak:
dermatology
drug repurposing
erlotinib
rare disease
stability indicating
Olmsted
Sarrera elektronikoa:https://www.mdpi.com/1420-3049/27/3/1070
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak